State Demands National Portal to Track Fake Drugs

He emphasized the limitations of state-specific procedures and the need for a unified national portal.

169
Lab Laboratory
Picture: Pixabay

Last Updated on December 2, 2024 by The Health Master

National Portal

National Portal: The alarming rise in cases of substandard and fake medicines has become a major public health concern.

These drugs, often lacking potency or containing harmful substances, can have devastating consequences for patients.

To address this pressing issue, Umesh S, the State Drugs Controller of Karnataka has called for a national portal to track and alert stakeholders about such products during a event of the All-India Drugs Control Officers’ Confederation at Bangaluru.

The Need for a Unified Approach

Umesh S, the State Drugs Controller of Karnataka, highlighted the importance of proactive and technology-driven regulatory enforcement.

He pointed to the state’s innovative SMS alert system, which notifies stakeholders about substandard medicines.

However, he emphasized the limitations of state-specific procedures and the need for a unified national portal.

A national portal would serve as a centralized platform, enabling the timely and transparent dissemination of information about compromised drugs across the country.

By integrating real-time data from state regulators, healthcare providers, and industry players, this portal could create a robust framework to prevent the circulation of substandard medicines.

Leveraging Technology for Enhanced Oversight

Sudarshan Jain, secretary-general of the Indian Pharmaceutical Alliance (IPA), underscored the role of digital transformation in enhancing regulatory oversight and transparency.

He drew parallels with the financial sector, where technology has revolutionized transactions.

Jain suggested that similar systems could be implemented to monitor drug distribution and facilitate the swift recall of faulty products.

Key Points

  • The increasing prevalence of substandard medicines poses a significant threat to public health.
  • A national-level portal is crucial for tracking and alerting stakeholders about compromised drugs.
  • Digital transformation can play a vital role in enhancing regulatory oversight and transparency.
  • By leveraging technology, we can create a safer and more reliable pharmaceutical supply chain.
  1. What are substandard medicines?

    Substandard medicines are drugs that fail to meet quality standards, either in terms of their composition, manufacturing process, or labeling.

  2. Why is a national portal necessary?

    A national portal would provide a centralized platform for tracking and alerting stakeholders about substandard medicines. It would help ensure consistency in regulatory practices across different states and facilitate timely interventions.

  3. How can digital technology improve drug safety?

    Digital technology can be used to track drug distribution, monitor supply chains, and enable rapid recall of faulty products. It can also facilitate data-driven decision-making and enhance transparency in the pharmaceutical industry.

Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

YouTube Icon

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos on consumer awareness, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news